PMID: 15168596Jun 1, 2004Paper

Phase I study of the combination of irinotecan hydrochloride, carboplatin, and dexamethasone for the treatment of relapsed or refractory malignant lymphoma

International Journal of Hematology
Junji SuzumiyaKyushu Hematology Organization for Treatment Study Group

Abstract

A phase I study of irinotecan hydrochloride (CPT-11), carboplatin, and dexamethasone treatment in 7 patients with relapsed lymphoma and 7 patients with refractory lymphoma was conducted to evaluate the maximal tolerated dose. The 6 female and 8 male patients had a median age of 63 years (range, 45-73 years), a median performance status of 0 (range, 0-2), and a median disease stage of IV. This study included patients with diffuse large B-cell lymphoma (n = 5), adult T-cell leukemia/lymphoma (n = 2), mantle cell lymphoma (n = 2), follicular lymphoma (n = 2), angioimmunoblastic T-cell lymphoma (n = 1), anaplastic large cell lymphoma (n = 1), and Hodgkin's lymphoma (n = 1). All patients had received anthracycline-containing combination chemotherapy prior to this therapy. The starting dosage of CPT-11 was 15 mg/m2 per day (days 1-3 and 8-10), and dosage-escalation increments of 5 mg/m2 per day were planned, with fixed dosages of carboplatin (250 mg/m2 per day, day 1) and dexamethasone (40 mg/body, days 1-3 and days 8-10). Five patients were enrolled at level 1, 3 at level 2, 4 at level 3, and 2 at level 4. Ten patients (71%) and 11 patients (79%) experienced grade 3 or 4 hematologic toxicities of leukocytopenia and neutropenia, resp...Continue Reading

References

Jan 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaN Masuda
Feb 20, 1992·International Journal of Cancer. Journal International Du Cancer·Y KanoY Miura
Nov 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R OhnoM Oguro
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W S VelasquezF Cabanillas
May 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y ShimadaN Ogawa
Feb 26, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T SaotomeJ Tamaru
Oct 31, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M GutierrezW H Wilson
Aug 11, 2001·Oncology·A H SarrisB Samuels

Citations

Aug 23, 2005·Cancer Chemotherapy and Biological Response Modifiers·Max KreditorHoward S Hochster
May 12, 2017·Journal of Biomedical Optics·Lian DuanHao F Zhang
Jan 20, 2018·Radiation Protection Dosimetry·Jérémie DabinPeter Kayaert
Jul 20, 2007·Physics in Medicine and Biology·Wayne NewhauserRadhe Mohan
Sep 13, 2008·Journal of Advanced Nursing·Felicity HassonDorry McLaughlin
Aug 17, 2011·International Journal of Health Services : Planning, Administration, Evaluation·Paula HollandMargaret Whitehead
Mar 18, 2008·International Journal of Health Services : Planning, Administration, Evaluation·Rebecca Ray, John Schmitt
Aug 31, 2018·International Journal of Sports Physiology and Performance·Steve H FaulknerGeorge Havenith
Jul 6, 2010·Physics in Medicine and Biology·R Behrens, G Dietze
Sep 10, 2010·Journal of Advanced Nursing·Ho Cheung William LiKa Yan Ho
Jul 16, 2014·The Journal of School Nursing : the Official Publication of the National Association of School Nurses·Rachel Jaffe, Julia Muennich Cowell
Nov 17, 2005·Journal of Neurovirology·Samson S Y Wong, K Y Yuen
Oct 20, 2005·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·M C ParkerSurgical and Clinical Adhesions Research (SCAR) Group
Oct 14, 2016·International Journal of Radiation Biology·François TrompierLaurence Roy
Jul 13, 2011·The American Journal of Bioethics : AJOB·Jennifer Prah Ruger
Jun 5, 2012·The Journal of the Association of Nurses in AIDS Care : JANAC·Dintletse Maria MagcaiAbel Jakobus Pienaar
Mar 4, 2014·Journal of Occupational and Environmental Hygiene·Jung-Hyun KimAitor Coca
Jul 22, 2016·Culture, Health & Sexuality·Teresita Rocha-JiménezShira M Goldenberg
Dec 17, 2015·Clinical Chemistry·Katsuyuki ShinoharaJapanese Committee for Clinical Laboratory Standards and the Japanese Association of Medical Technologists
Apr 8, 2016·Journal of Food Protection·Danilo Augusto Lopes da SilvaLúis Augusto Nero
Jun 15, 2016·Journal of Food Protection·Jim McLauchlinCaroline Willis
Feb 25, 2011·Journal of Radiological Protection : Official Journal of the Society for Radiological Protection·L A Jones, R P Stokes
Feb 18, 2017·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·Ben BeckBelinda Gabbe

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.